Covered recipient · General Payments record
ETHEL C ESTRADA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$676.12
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.26 | 9 |
| Education | $65.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $125.90 | 3 |
| Lilly USA, LLC | $50.24 | 2 |
| Acerta Pharma LLC | $34.12 | 1 |
| TAIHO ONCOLOGY, INC. | $33.66 | 1 |
| Blueprint Medicines Corporation | $32.22 | 1 |
| BeiGene USA, Inc. | $31.32 | 1 |
| Invivyd Inc | $18.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $29.50 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139541796 | CMS |
| Astellas Pharma US Inc | $65.00 | 10/17/2024 | Education | Undisputed | 01/23/2026 | 1139546511 | CMS |
| Astellas Pharma US Inc | $31.40 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139548123 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.12 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104766200 | CMS |
| BeiGene USA, Inc. | $31.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120854231 | CMS |
| Blueprint Medicines Corporation | $32.22 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147447066 | CMS |
| Invivyd Inc | $18.80 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147384845 | CMS |
| Lilly USA, LLC | $28.88 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135667856 | CMS |
| Lilly USA, LLC | $21.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135670658 | CMS |
| TAIHO ONCOLOGY, INC. | $33.66 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137934043 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.